Ann: Chairman's Address to Shareholders and Presentation, page-29

You touched on what I think is the key short/medium term point there, and you're slightly more optimistic than I.

I am not convinced that doing two trials for the FDA has been fully priced in. If it has, then this is a screaming buy as it literally can only go up. However, I'm reticent to commit as I think an ann confirming the two trials will hurt the SP and may result in a second cap raise?

If so, that hurts the capacity of the SP rising in the short-medium term.

I am optimistic overall on this stock, but that is the point of concern that I am grappling with currently.